| Advanced Patent Prosecution Workshop 2012 TOC |
|
|
| Chapter 1: Prosecution Ethics, Including Therasense v. Becton Dickinson |
Robert C. Faber ~ Ostrolenk Faber LLP
|
|
| Chapter 2: Therasense, Inc. v. Becton Dickinson & Co., 649 F. 3d 1276, 99 U.S.P.Q. 2d 1065 (Fed. Cir., May 2011) |
Robert C. Faber ~ Ostrolenk Faber LLP
|
|
| Chapter 3: Section 1.56 Duty to Disclose Information Material to Patentability |
Robert C. Faber ~ Ostrolenk Faber LLP
|
|
| Chapter 4: Section 10.20 et seq. Canons and Disciplinary Rules |
Robert C. Faber ~ Ostrolenk Faber LLP
|
|
| Chapter 5: Drafting an Effective Specification for the Chemical Patent Application |
John C. Todaro ~ Managing Counsel, Intellectual Property Group, Merck & Co., Inc.
|
|
| Chapter 6: Advanced Patent Specification Drafting Issues |
Alicia Russo ~ Fitzpatrick, Cella, Harper & Scinto
|
|
| Chapter 7: Advanced Specification Drafting Issues: Electronic and Computer Inventions |
Kenneth N. Nigon ~ RatnerPrestia, P.C.
|
|
| Chapter 8: Formulation Patents and Obviousness |
Michael A. Davitz, M.D. ~ Fahmi, Sellers, Embert & Davitz LLP
|
|
| Chapter 9: The Winning Mechanical Claim |
Robert C. Faber ~ Ostrolenk Faber LLP
|
|
| Chapter 10: Crafting the Claims |
Ann M. McCrackin ~ Schwegman Lundberg & Woessner, P.A.
|
|
| Chapter 11: First Inventor to File Under the America Invents Act |
John A. O'Brien ~ Law Offices of John A. O'Brien, P.C.
|
|
| Chapter 12: Outline of Post-Grant United States Patent and Trademark Office ("USPTO") Proceedings: Pre-and Post-America Invents Act ("AIA") |
Michael K. Levy ~ Kenyon & Kenyon LLP
|
|
| Chapter 13: Drafting Claims for Chemical and Pharmaceutical Patent Applications |
Jay P. Lessler ~ Blank Rome LLP
|
|
| Chapter 14: The Leahy-Smith America Invents Act |
Gerard F. Diebner ~ Tannenbaum Helpern Syracuse & Hirschtritt LLP
|
|
| Chapter 15: Is Obviousness a Moving Target Under KSR? |
Thomas J. Kowalski ~ Vedder Price P.C.
Deborah L. Lu, Ph.D. ~ Vedder Price P.C.
|
|
| Chapter 16: Using Federal Circuit Law to Overcome an Obviousness Rejection |
Rebecca Goldman Rudich ~ Vedder Price P.C.
|
|
| Chapter 17: The Use of "Means Plus Function" Language in Patent Claims |
Robert D. Schaffer ~ Pearl Cohen Zedek Latzer LLP
|
|
| Chapter 18: Responding to the "Difficult" Obviousness Rejection |
Michael P. Dunnam ~ Woodcock Washburn LLP
|
|
| Chapter 19: Life After Bilski: Has Bilski Provided the Clarity We Had All Hoped For? |
Michael P. Dunnam ~ Woodcock Washburn LLP
|
|
| Chapter 20: The U.S. on the Patent Prosecution Highway |
J. Robert Dean, Jr. ~ Ohlandt, Greeley, Ruggiero & Perle, LLP
|
|
| Chapter 21: Ethics Issues for Patent Prosecutors |
Burt Magen ~ Vierra Magen Marcus LLP
|
|
| Chapter 22: Countering the Obviousness Rejection |
Sanjeet K. Dutta ~ King & Spalding LLP
|
|
| Chapter 23: Article of Manufacture Claims for Computer Related Inventions |
Burt Magen ~ Vierra Magen Marcus LLP
|
|
| Chapter 24: Advanced Claim and Specification Drafting: "It's All About Claim Construction" |
Jean Burke Fordis ~ Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
|
|
| Chapter 25: The Unsettled Law of Patent Eligible Subject Matter |
Stuart P. Meyer ~ Partner, Fenwick & West LLP
Rajiv P. Patel ~ Fenwick & West LLP
|
|
| Chapter 26: Patentable Subject Matter in Biotechnology |
Joseph R. Snyder, Ph.D. ~ Kilpatrick Townsend & Stockton LLP
|
|
| Chapter 27: Duty of Disclosure and Inequitable Conduct Post Therasense & AIA |
Roxana Yang ~ PatentEsque Law Group, LLP
|
|
| Chapter 28: Written Description Issues and Practical Considerations in Patent Specification Drafting |
Christopher M. Tobin ~ Rader, Fishman & Grauer PLLC
|
|
| Chapter 29: Understanding After Final and After Allowance Patent Practice |
Rajiv P. Patel ~ Fenwick & West LLP
Daniel R. Brownstone ~ Fenwick & West LLP
Robert Hulse ~ Fenwick & West LLP
|
|
| Chapter 30: Prosecution Under the America Invents Act |
Jeffrey A. Miller ~ Dickstein Shapiro LLP
|
|
| Chapter 31: Index to Advanced Patent Prosecution Workshop 2012 |
|
|